Over 3000 industry leading figures from the world of medicine and healthcare will be hosted by Olympia Events at the inaugural London Biotechnology Show this May.
The global biotechnology market was estimated at $1,023.92 billion in 2021. As countries across the world move to create a more sustainable future, many are turning to biotechnology to create a low-carbon economy whilst advancements in the industry are preventing, diagnosing and treating diseases more effectively than ever before.
The exhibition and conference on May 8 – 9 will bring together policymakers, business leaders and investors to debate the latest advancements in biotechnology around the globe. The latest products, services and solutions will also be on show for attendees to explore with Olympia’s West hall set to be the hub of discussion around the transforming world of biotechnology.
Topics covered at the conference include:
- Emerging trends and directions in Clinical Trials
- New methods to improve patient experience
- Advancements in Biomaterials
- Precision medicine in ageing & longevity
- AI in healthcare diagnostics and drug discovery
Sarah Collins, Commercial Director for the UK Health Security Agency, will give the keynote address with the UK Government’s support for the Life Sciences on the agenda.
“This event will be a game-changer for the world of biotechnology, bringing together industry leading figures in our Olympia West venue. It’s fantastic to be able to facilitate this inaugural event and play a part in the future of the medical and healthcare sectors.” Anna Golden, Commercial Director, Olympia Events.
The event will be bustling with opportunities to network throughout with people at the forefront of the cutting edge biotechnology world in west London over the two days.
Learn more about the event and register now to attend, with free visitor passes also available.